Accentia Biopharmaceuticals Conducts Investigator Meeting in Preparation for New Multiple Sclerosis Drug Study for Cyrevia™
Businesswire.com, 04 May 2012
Accessed on 11 May 2012 from http://www.businesswire.com/news/home/20120504005213/en/Accentia-Biopharmaceuticals-Conducts-Investigator-Meeting-Preparation-Multiple.